Clinical Trial
Transdiagnostic Circuit Mapping of Prefrontal Targets in Accelerated Transcranial Magnetic Stimulation
ClinicalTrials.gov1/30/2025·01/30/25🌐 USA
Summary
This Phase 2 trial maps prefrontal circuit targets for accelerated transcranial magnetic stimulation across psychiatric conditions including obsessive-compulsive disorder, major depression, and schizophrenia. Using functional connectivity MRI, the study identifies personalized TMS targets to optimize treatment response.
Why it matters
Current TMS for OCD uses standardized targets with variable efficacy. This transdiagnostic circuit mapping approach could identify optimal stimulation sites tailored to each patient's unique neural circuitry, representing a major advance toward precision neuromodulation for psychiatric disorders.
#Phase 2#OCD#Neurostimulation#TMS#Non-invasive#Neuroimaging#Neurodiagnostics#USA
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in